https://www.nature.com/articles/d41586-022-02050-x.
24. Zhang W Y, Wang Y, Guo Y L, et al. Treatment of CD20-directed
Chimeric Antigen Receptor-modified T cells in patients with relapsed or
refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report
[J]. Signal Transduction & Targeted Therapy, 2016, 1:16002.
Table 1 Comparison of basic population information between groups